Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SWX/NOVN stock hub

SWX/NOVN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/NOVNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

216.3B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/NOVN

In the news

Latest news · SWX/NOVN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5

P25 15.9P50 20.7P75 33.1

Trailing P/E20.2

P25 19.6P50 21.4P75 37.6

ROE34.9

P25 -6.1P50 7.9P75 17

ROIC21.1

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/NOVN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	75,267
Employees Change	-616%
Employees Change Percent	-0.81
Enterprise value	CHF 248.8B
Exchange	SIX Swiss Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CH0012005267
Last refreshed	2026-05-10
Market cap	CHF 216.3B
Price	CHF 113
Price currency	CHF
Rev Per Employee	602,951.43x
Sector	Healthcare
Sic	2834
Symbol	swx/NOVN
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.02%
EV Earnings	22.92x
EV/EBIT	16.85x
EV/EBITDA	13.37x
EV/FCF	17.69x
EV/Sales	5.48x
FCF yield	6.5%
Forward P/E	16.49x
P/B ratio	6.93x
P/E ratio	20.24x
P/S ratio	4.77x
PE Ratio10 Y	20.03x
PE Ratio3 Y	18.04x
PE Ratio5 Y	17.39x
PEG ratio	1.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.56%
EBITDA Margin	40.51%
FCF margin	30.99%
Gross margin	75.55%
Gross Profit	CHF 34.3B
Gross Profit Growth	6.14%
Gross Profit Growth Q	-2.95%
Gross Profit Growth3 Y	10.99%
Gross Profit Growth5 Y	3.98%
Net Income	CHF 10.9B
Net Income Growth	5.25%
Net Income Growth Q	-12.48%
Net Income Growth Years	1%
Net Income Growth3 Y	24.42%
Net Income Growth5 Y	11.21%
Pretax Margin	27.9%
Profit Margin	23.92%
Profit Per Employee	CHF 144,232
Profitable Years	28
ROA	10.54
Roa5y	7.4
ROCE	21.14
ROE	34.93
Roe5y	23.91
ROIC	21.1
Roic5y	17.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.64%
Cagr15y	10.4%
Cagr1y	27.24%
Cagr20y	7.1%
Cagr3y	12.42%
Cagr5y	12.6%
Div CAGR10	3.2%
Div CAGR3	4.96%
Div CAGR5	4.28%
EPS Growth	9.48
EPS Growth Q	-9.34
EPS Growth Years	1
EPS Growth3 Y	29.06
EPS Growth5 Y	14.94
FCF Growth	-0.4%
FCF Growth Q	-1.8%
FCF Growth3 Y	6.01%
FCF Growth5 Y	7.94%
OCF Growth	0.93%
OCF Growth Q	0.85%
OCF Growth10 Y	5.03%
OCF Growth3 Y	7.25%
OCF Growth5 Y	7.67%
Revenue Growth	6.31x
Revenue Growth Q	-0.71x
Revenue Growth Years	3x
Revenue Growth3 Y	10.71x
Revenue Growth5 Y	2.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.52
Assets	CHF 95.1B
Cash	CHF 5.5B
Current Assets	CHF 20.7B
Current Liabilities	CHF 24.4B
Debt	CHF 37.7B
Debt EBITDA	CHF 2.03
Debt Equity	CHF 1.21
Debt FCF	CHF 2.68
Equity	CHF 31.2B
Interest Coverage	15.14
Liabilities	CHF 63.9B
Long Term Assets	CHF 74.4B
Long Term Liabilities	CHF 39.5B
Net Cash	CHF -32.2B
Net Cash By Market Cap	CHF -14.87
Net Debt EBITDA	CHF 1.75
Net Debt Equity	CHF 1.03
Net Debt FCF	CHF 2.29
Tangible Book Value	CHF -22.9B
Tangible Book Value Per Share	CHF -11.99
WACC	6.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	2.28
Net Working Capital	CHF -3B
Quick ratio	0.53
Working Capital	CHF -3.8B
Working Capital Turnover	CHF -8.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.8%
Dividend Growth	5.71%
Dividend Growth Years	29%
Dividend per share	CHF 3.7
Dividend Years	30
Dividend Yield	3.26%
Ex Div Date	2026-03-10
Last Dividend	CHF 3.7
Payout Frequency	Annual
Payout Ratio	64.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	174.86%
1Y total return	27.22%
200-day SMA	109.4
3Y total return	42.1%
50-day SMA	119.9
50-day SMA vs 200-day SMA	50over200
5Y total return	81%
All Time High	131
All Time High Change	-13.47%
All Time High Date	2026-02-27
All Time Low	37.13
All Time Low Change	205.35%
All Time Low Date	1996-12-24
ATR	2.41
Beta	0.49
Beta1y	0.72
Beta2y	0.69
Ch YTD	3.43
High	114
High52	131
High52 Date	2026-02-27
High52ch	-13.47%
Low	112.8
Low52	87.89
Low52 Date	2025-05-15
Low52ch	28.98%
Ma50ch	-5.42%
Price vs 200-day SMA	3.66%
RSI	40.16
RSI Monthly	59.2
RSI Weekly	49.58
Sharpe ratio	1.13x
Sortino ratio	1.91
Total Return	7.06%
Tr YTD	6.58
Tr15y	340.8%
Tr1m	-5.38%
Tr1w	-0.42%
Tr3m	-2.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 14.8B
Operating Income Growth	4.47
Operating Income Growth Q	-12.37
Operating Income Growth3 Y	20.99
Operating Income Growth5 Y	10.06
Operating margin	32.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,816,121,384%
Net Borrowing	11,286,048,330
Shares Insiders	0.11%
Shares Institutions	44.44%
Shares Out	1,908,091,965
Shares Qo Q	-0.67%
Shares Yo Y	-3.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 13.2B
Average Volume	2,508,127.15x
Bv Per Share	16.19
CAPEX	CHF -1.3B
Ch10y	60.23
Ch15y	114.9
Ch1m	-5.38
Ch1w	-0.42
Ch1y	23.46
Ch20y	62.06
Ch3m	-5.5
Ch3y	21.62
Ch5y	42.61
Ch6m	11.14
Change	0.05%
Change From Open	0.09
Close	113.3
Days Gap	-0.04
Depreciation Amortization	3,495,520,545
Dollar Volume	174,949,281.5
Earnings Date	2026-04-28
EBIT	CHF 14.8B
EBITDA	CHF 18.4B
EPS	CHF 5.6
F Score	5
FCF	CHF 14.1B
FCF EV Yield	5.65x
FCF Per Share	CHF 7.37
Financing CF	-2,197,808,800
Fiscal Year End	December
Founded	1,996
Goodwill	20,837,156,145
Graham Number	45.76883
Graham Upside	-59.63
Income Tax	CHF 1.8B
Investing CF	-13,590,319,160
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2001-05-07
Last Split Type	Forward
Lynch Fair Value	CHF 63.8
Lynch Upside	-43.72
Ma150	113.1
Ma150ch	0.24%
Ma20	116.2
Ma20ch	-2.48%
Net CF	-151,600,680
Next Earnings Date	2026-07-21
Open	113.3
P FCF Ratio	15.38
P OCF Ratio	14.06
Payment Date	2026-03-12
Position In Range	43.33
Ppne	9,508,375,290
Price Date	2026-05-08
Price EBITDA	CHF 11.76
Relative Volume	0.62x
Revenue	45,382,345,360x
SBC By Revenue	2.01x
Share Based Comp	912,010,440
Tax By Revenue	4.01x
Tax Rate	14.38%
Tr20y	294.43%
Tr6m	14.52%
Volume	1,543,307
Z Score	3.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/NOVN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$3.70 annual per share

Payout ratio

+64.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.3%

29 consecutive years of growth

Total shareholder yield

+7.1%

Next ex-dividend date: 2026-03-10

Performance

SWX/NOVN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/NOVN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.8%

Negative means the company is buying back shares.

Technical

SWX/NOVN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

+3.7%

50/200-day relationship not available

Beta (5Y)

0.49

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/NOVN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/NOVN stock rating?

swx/NOVN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/NOVN analysis?

The full report lives at /stocks/swx/NOVN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/NOVN?

The latest report frames swx/NOVN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/NOVN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.